Tumor-derived microparticles-based nanomaterial as platform for delivery of tumor antigens to enhance immunogenicity

Qi Tan,Zimo Yang,Shichen Bu,Jiangbin Chen,Wenjuan Chen,Wei Geng,Qi Huang,Limin Duan,Mengfei Guo,Yali Wu,Jingjing Deng,E Zhou,Minglei Li,Feng Wu,Yang Jin

DOI: https://doi.org/10.1016/j.cej.2023.142497

IF: 15.1

2023-03-30

Chemical Engineering Journal

Abstract:Background Tumor‐derived microparticles (TMPs) are not only carriers for tumor antigens but also can be used as good delivery platform. Therefore, for such an excellent delivery platform, we considered modifying TMPs with lipopolysaccharide (LPS) and polyethyleneimine (PEI) to synthesize TMPs-PEI-LPS for the delivery of tumor antigen and investigated its delivery efficiency, histocompatibility and anti-tumor effect. Result We investigated the bioactivity of TMPs-PEI-LPS with dendritic cells and their potential for therapeutic application to treat lung cancer in mice models bearing Lewis lung carcinoma cells. Both in vitro and in vivo assays demonstrated successful TMPs-PEI-LPS induced the uptake and maturity of dendritic cells. TMPs-PEI-LPS exhibited certain immunostimulation activity and anti-tumor effects on inhibiting tumor growth in vivo . Notably, TMPs-PEI-LPS were safe and non-toxic in vivo study. Conclusion These results indicated that TMPs-PEI-LPS are promising platforms for delivering tumor antigens to enhance immunogenicity.

engineering, chemical, environmental